Global High Growth Potential Companies

Fawry for Banking Technology and Electronic PaymentsE

Market Cap: ج.م46.7b

Fawry for Banking Technology and Electronic Payments S.A.E.

I.CO.P.. Società Benefit

Market Cap: €572.5m

Engages in providing construction and special engineering services to public and private clients in Italy and internationally.

Visual Photonics Epitaxy

Market Cap: NT$28.4b

Engages in the research and development, manufacture, and sale of optoelectronic semiconductors epitaxy and optoelectronic components products in Taiwan, the United States, and internationally.

KebNi

Market Cap: SEK 645.3m

Develops, produces, and sells products and applications for stabilization, navigation, and satcom worldwide.

Cox ABG Group

Market Cap: €829.1m

Operates as an integrated utility of water and energy company.

Pharma Mar

Market Cap: €1.6b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

CD Projekt

Market Cap: zł25.2b

Together its subsidiaries, engages in the development, publishing, and digital distribution of video games for personal computers and video game consoles in Poland.

ErreDue

Market Cap: €44.7m

Offers on-site production, mixing, and purification of technical gases solutions in Italy.

Elliptic Laboratories

Market Cap: NOK 1.1b

An artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan.

AVITA Medical

Market Cap: US$139.0m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Guinness Nigeria

Market Cap: ₦313.2b

Engages in brewing, packaging, marketing, and selling whisky, vodka, liqueur, gin, spirits, beers, non-alcoholic drinks, and ready-to-drink products primarily in Nigeria.

Axsome Therapeutics

Market Cap: US$5.9b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Novavis Group

Market Cap: zł43.5m

Engages in developing, designing, and executing renewable energy sources projects in Poland.

Altea Green Power

Market Cap: €130.9m

Provides renewable energy systems for individuals, companies, institutions and investors in Italy.

Construtora Tenda

Market Cap: R$3.2b

Operates as a construction company in Brazil.

NVIDIA

Market Cap: US$4.3t

A computing infrastructure company, provides graphics and compute and networking solutions in the United States, Singapore, Taiwan, China, Hong Kong, and internationally.

Credo Technology Group Holding

Market Cap: US$28.0b

Provides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.

Carvana

Market Cap: US$78.9b

Operates an e-commerce platform for buying and selling used cars in the United States.

Intellego Technologies

Market Cap: SEK 5.4b

Manufactures and sells colorimetric ultraviolet indicators in Sweden.

Propel Holdings

Market Cap: CA$1.3b

Operates as a financial technology company.

Zevra Therapeutics

Market Cap: US$435.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

M Vest Water

Market Cap: NOK 265.0m

An environmental technology company, develops products and solutions for the water treatment industry in Norway, Iceland, Austria, Switzerland, and Oman.

TG Therapeutics

Market Cap: US$4.7b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Rheinmetall

Market Cap: €87.0b

Provides mobility and security technologies in Germany; the rest of Europe; North, Middle, and South America; Asian regions, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$61.1b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Gold Circuit Electronics

Market Cap: NT$237.0b

Designs, manufactures, processes, and distributes printed circuit boards in Taiwan.

Ascendis Pharma

Market Cap: US$11.8b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Travere Therapeutics

Market Cap: US$2.1b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Time Interconnect Technology

Market Cap: HK$34.2b

An investment holding company, manufactures and sells cable assembly, digital cable, and server products in the People's Republic of China, the United States, Singapore, the Netherlands, Hong Kong, Mexico, the United Kingdom, and internationally.

Chongqing Baiya Sanitary Products

Market Cap: CN¥12.3b

Chongqing Baiya Sanitary Products Co., Ltd.

Laopu Gold

Market Cap: HK$125.8b

Designs, manufactures, and sells jewelry products in Mainland China, Hong Kong, and Macau.

Pop Mart International Group

Market Cap: HK$367.6b

An investment holding company, engages in the design, development, and sale of pop toys in the People’s Republic of China, Hong Kong, Macao, Taiwan, and internationally.

CARsgen Therapeutics Holdings

Market Cap: HK$11.4b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

Bloks Group

Market Cap: HK$23.2b

Engages in the design, development, and sales of toy products in Mainland China.

Ascentage Pharma Group International

Market Cap: HK$29.1b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$115.8b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.